NASDAQ:BHTG - BioHiTech Global Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 198.51 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.34
▼ -0.04 (-2.90%)
1 month | 3 months | 12 months
Get New BioHiTech Global Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BHTG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHTG

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$4.00
▲ +198.51% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for BioHiTech Global in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 198.51% upside from the last price of $1.34.
Buy
The current consensus among 1 contributing investment analysts is to buy stock in BioHiTech Global. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/2/2020Maxim GroupReiterated RatingBuy$4.00Low
i
5/28/2020Maxim GroupReiterated RatingBuy$2.50Medium
i
2/2/2020Maxim GroupReiterated RatingBuy$3.50Low
i
10/17/2019Maxim GroupReiterated RatingBuy$2.75Low
i
8/16/2019Maxim GroupSet Price TargetBuy$3.00Low
i
Rating by Tate Sullivan at Maxim Group
7/22/2019Ascendiant Capital MarketsInitiated CoverageBuy$5.00 ➝ $5.00High
i
4/2/2019Maxim GroupReiterated RatingBuy$7.00High
i
5/17/2018Maxim GroupReiterated RatingBuy$7.00Low
i
(Data available from 4/21/2016 forward)
BioHiTech Global logo
BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions for the control, reduction, and/or reuse of organic and municipal waste worldwide. Its suite of technologies includes on-site biological processing equipment for food waste, patented processing facilities for the conversion of municipal solid waste into renewable fuel, and proprietary real-time data analytics tools to reduce food waste generation. The company also markets Revolution Series Digesters, an aerobic digestion technology solution for the disposal of food waste at the point of generation; and High Efficiency Biological Treatment Resource Recovery Technology to process waste at the municipal or enterprise level. In addition, it offers BioHiTech Cloud and Cirrus mobile applications for digester customers. Its principal customers include producers of food waste. The company serves healthcare, grocery, prison, retail food service, and hospitality industries, as well as food distributors, governments, conference centers, municipalities and academic institutions, stadiums. BioHiTech Global, Inc. is headquartered in Chestnut Ridge, New York.
Read More

Today's Range

Now: $1.34
$1.31
$1.37

50 Day Range

MA: $1.64
$1.35
$1.98

52 Week Range

Now: $1.34
$1.05
$4.40

Volume

628,601 shs

Average Volume

2,149,927 shs

Market Capitalization

$26.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44

Frequently Asked Questions

What sell-side analysts currently cover shares of BioHiTech Global?

The following equities research analysts have issued research reports on BioHiTech Global in the last year: Maxim Group.
View the latest analyst ratings for BHTG.

What is the current price target for BioHiTech Global?

1 Wall Street analysts have set twelve-month price targets for BioHiTech Global in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 198.5%. Maxim Group has the highest price target set, predicting BHTG will reach $4.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $4.00 for BioHiTech Global in the next year.
View the latest price targets for BHTG.

What is the current consensus analyst rating for BioHiTech Global?

BioHiTech Global currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BHTG will outperform the market and that investors should add to their positions of BioHiTech Global.
View the latest ratings for BHTG.

What other companies compete with BioHiTech Global?

How do I contact BioHiTech Global's investor relations team?

BioHiTech Global's physical mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company's listed phone number is 845-262-1081 and its investor relations email address is [email protected] The official website for BioHiTech Global is www.biohitech.com.